Evidence map›Paper›PMID 31191127›Full record

ArticleProceedings (Baylor University. Medical Center)2019

Relation of postoperative pain medication to return for unplanned care after ureteroscopy.

Preston A Milburn, Kim H Thai, Amr El Mekresh, Patrick S Lowry, Marawan M El Tayeb

Abstract read
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Preston A MilburnDivision of Urology, Department of Surgery, Scott & White Medical Center-TempleTempleTexas.
Kim H ThaiDivision of Urology, Department of Surgery, Scott & White Medical Center-TempleTempleTexas.ORCID 0000-0002-6007-6352
Amr El MekreshDivision of Urology, Department of Surgery, Scott & White Medical Center-TempleTempleTexas.
Patrick S LowryDivision of Urology, Department of Surgery, Scott & White Medical Center-TempleTempleTexas.ORCID 0000-0003-0806-7413
Marawan M El TayebDivision of Urology, Department of Surgery, Scott & White Medical Center-TempleTempleTexas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To determine whether the US Drug Enforcement Agency (DEA) class of narcotics prescribed to patients after ureteroscopy impacts their rate of return for unplanned care, a retrospective analysis of patients from February 2014 through March 2016 was performed. Data were collected for the first 90 days after surgery. Patients were divided into groups based on the narcotics schedule prescribed after surgery. Results showed that there was no statistical difference in return for unplanned care when comparing the groups based on their prescribed pain medication. Among the 475 patients, 17% returned to the emergency department after ureteroscopy, 12% contacted the clinic due to discomfort/pain, and 8% were readmitted to the hospital within 90 days of surgery. The data indicated that patients who were not prescribed a narcotic after surgery sought unplanned care at a slightly higher rate than those who were. In conclusion, the US DEA class of narcotics prescribed after ureteroscopy did not have a statistically significant impact on the rate of return for unplanned care. These findings may improve opioid stewardship in patients undergoing outpatient ureteroscopy.

Indexed as

Narcoticsnephrolithiasispainreadmissionureteroscopy

Identifiers

PMID31191127
PMCPMC6541049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.